Literature DB >> 23498720

Role of MYCN in retinoblastoma.

Dean W Felsher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23498720     DOI： 10.1016/S1470-2045(13)70070-6

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  10 in total

Review 1.  A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.

Authors:  Sarah Scollon; Amanda Knoth Anglin; Martha Thomas; Joyce T Turner; Kami Wolfe Schneider
Journal:  J Genet Couns       Date:  2017-03-29       Impact factor: 2.537

2.  Computational and in vitro Investigation of miRNA-Gene Regulations in Retinoblastoma Pathogenesis: miRNA Mimics Strategy.

Authors:  Nalini Venkatesan; Perinkulam Ravi Deepa; Vikas Khetan; Subramanian Krishnakumar
Journal:  Bioinform Biol Insights       Date:  2015-05-12

3.  Prediction and analysis of retinoblastoma related genes through gene ontology and KEGG.

Authors:  Zhen Li; Bi-Qing Li; Min Jiang; Lei Chen; Jian Zhang; Lin Liu; Tao Huang
Journal:  Biomed Res Int       Date:  2013-08-13       Impact factor: 3.411

4.  Genistein suppresses retinoblastoma cell viability and growth and induces apoptosis by upregulating miR-145 and inhibiting its target ABCE1.

Authors:  Dong Wei; Lieying Yang; Bo Lv; Lijuan Chen
Journal:  Mol Vis       Date:  2017-07-03       Impact factor: 2.367

Review 5.  The MYCN Protein in Health and Disease.

Authors:  María Victoria Ruiz-Pérez; Aine Brigette Henley; Marie Arsenian-Henriksson
Journal:  Genes (Basel)       Date:  2017-03-30       Impact factor: 4.096

6.  Cell-free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experience.

Authors:  Prachi Kothari; Francesco Marass; Julie L Yang; Caitlin M Stewart; Dennis Stephens; Juber Patel; Maysun Hasan; Xiaohong Jing; Fanli Meng; Jeanette Enriquez; Kety Huberman; Agnes Viale; Jasmine H Francis; Michael F Berger; Neerav Shukla; David H Abramson; Ira J Dunkel; Dana W Y Tsui
Journal:  Cancer Med       Date:  2020-07-07       Impact factor: 4.452

7.  LncRNA CANT1 suppresses retinoblastoma progression by repellinghistone methyltransferase in PI3Kγ promoter.

Authors:  Hongyan Ni; Peiwei Chai; Jie Yu; Yue Xing; Shaoyun Wang; Jiayan Fan; Shengfang Ge; Yefei Wang; Renbing Jia; Xianqun Fan
Journal:  Cell Death Dis       Date:  2020-05-04       Impact factor: 8.469

8.  PRELP Regulates Cell-Cell Adhesion and EMT and Inhibits Retinoblastoma Progression.

Authors:  Jack Hopkins; Ken Asada; Alex Leung; Vasiliki Papadaki; Hongorzul Davaapil; Matthew Morrison; Tomoko Orita; Ryohei Sekido; Hirofumi Kosuge; M Ashwin Reddy; Kazuhiro Kimura; Akihisa Mitani; Kouhei Tsumoto; Ryuji Hamamoto; Mandeep S Sagoo; Shin-Ichi Ohnuma
Journal:  Cancers (Basel)       Date:  2022-10-08       Impact factor: 6.575

9.  Dynamic chromosomal tuning of a novel GAU1 lncing driver at chr12p13.32 accelerates tumorigenesis.

Authors:  Peiwei Chai; Ruobing Jia; Renbing Jia; Hui Pan; Shaoyun Wang; Hongyan Ni; Huixue Wang; Chuandi Zhou; Yingyun Shi; Shengfang Ge; He Zhang; Xianqun Fan
Journal:  Nucleic Acids Res       Date:  2018-07-06       Impact factor: 16.971

10.  Bioinformatics analysis of multi-omics data identifying molecular biomarker candidates and epigenetically regulatory targets associated with retinoblastoma.

Authors:  Yuyang Zeng; Tao He; Juejun Liu; Zongyuan Li; Feijia Xie; Changzheng Chen; Yiqiao Xing
Journal:  Medicine (Baltimore)       Date:  2020-11-20       Impact factor: 1.817
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.